Ruedi Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Ruedi Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23	Closed	-$11.4K	–	296
2025 Q1	$11.4K	Hold	23	–	–	﹤0.01%	155
2024 Q4	$12K	Hold	23	–	–	﹤0.01%	155
2024 Q3	$14.2K	Sell	23 -13	-36%	-$7.7K	﹤0.01%	147
2024 Q2	$19.9K	Buy	36 +13	+57%	+$7.45K	0.01%	126
2024 Q1	$13.4K	Buy	+23	New	+$12.9K	0.01%	145

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ruedi Wealth Management's TMO Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 23 shares — an estimated $11.4K sold.

Ruedi Wealth Management first reported a position in TMO in Q1 2024 and held it in 5 quarters. The position peaked at $19.9K in Q2 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Ruedi Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Ruedi Wealth Management sold 23 Thermo Fisher Scientific shares in Q2 2025, an estimated $11.4K.
Ruedi Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 5 quarters.
Ruedi Wealth Management's Thermo Fisher Scientific position peaked at $19.9K in Q2 2024.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.